REGEN 2026, the two-day international regenerative medicine conference held on September 5–6 in Mumbai, brought together leading orthopedic and regenerative medicine experts from India, France, Brazil, Italy and the USA to advance evidence-based regenerative orthopedics.
A key highlight of the conference is the official unveiling of the first internationally developed BMAC (Bone Marrow Aspirate Concentrate) Consensus Guidelines, jointly developed by leading experts from India, Europe and the USA. The guidelines represent a collaborative effort to establish greater consistency and an evidence-based framework for the clinical use of BMAC in regenerative orthopedics.
The conference also featured the presentation of a new biological classification for knee osteoarthritis by Dr Sharmila Tulpule, offering a perspective beyond the conventional Kellgren-Lawrence radiographic system and highlighting the importance of biological factors in assessing osteoarthritis.
Speaking at the conference, Dr Sharmila Tulpule, Chairperson, REGEN 2026, said, “REGEN 2026 is about moving regenerative orthopedics from promise to evidence-based practice. The development of these BMAC Consensus Guidelines through collaboration among experts from India, Europe, South America and the USA marks an important step towards greater clinical consistency, informed decision-making and better patient care. Our aim is to bring global expertise and Indian clinical experience together to shape standards relevant to everyday practice.”
The two-day conference featured international experts including Prof. Nicola Maffulli, Dr Fabio Sciarretta, Dr Nathan Katz, Dr Don Buford and Dr Massimo Piracci, alongside leading Indian specialists. Discussions covered PRP, BMAC, MFAT and other orthobiologics, with sessions focusing on clinical evidence, patient selection, treatment protocols and emerging regenerative technologies.
Dr Madhan Jeyaraman, Founder Director, Agathisha Institute of Stem Cell and Regenerative Therapy, Chennai, said, “The significance of the BMAC Consensus Guidelines lies not only in the recommendations themselves, but in the international collaboration behind them. Experts from India, Europe and the USA have come together to create a common, evidence-led framework that can help bring greater consistency to BMAC practice.”
The event also featured the ABRM (American Board of Regenerative Medicine) Convocation Ceremony, conferring Diplomate status on Indian practitioners.
Niteen Tulpule, Treasurer, REGEN 2026, said, “Following the success of our inaugural edition in 2025, REGEN 2026 brings together experts from India, Europe, South America and the USA to advance evidence-based regenerative orthopedics. The development of the BMAC Consensus Guidelines through this international collaboration is an important step towards creating practical, consistent and evidence-led frameworks for regenerative medicine, ultimately supporting better patient care.”
With its focus on consensus-building, scientific evidence and practical clinical learning, REGEN 2026 reinforced the need for stronger evidence-based standards in regenerative orthopedics in India.